Addex Therapeutics Ltd (SWX:ADXN)
0.0534
0.00 (0.00%)
At close: Dec 5, 2025
Addex Therapeutics Revenue
Addex Therapeutics had revenue of 36.38K CHF in the quarter ending June 30, 2025, a decrease of -68.45%. This brings the company's revenue in the last twelve months to 167.29K, down -79.93% year-over-year. In the year 2024, Addex Therapeutics had annual revenue of 410.04K, down -74.64%.
Revenue (ttm)
167.29K
Revenue Growth
-79.93%
P/S Ratio
39.26
Revenue / Employee
79.27K
Employees
2
Market Cap
6.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 410.04K | -1.21M | -74.64% |
| Dec 31, 2023 | 1.62M | 172.23K | 11.92% |
| Dec 31, 2022 | 1.44M | -1.71M | -54.18% |
| Dec 31, 2021 | 3.15M | -725.84K | -18.71% |
| Dec 31, 2020 | 3.88M | 1.05M | 36.89% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.49B |
| Novartis AG | 44.95B |
| Galderma Group AG | 3.73B |
| Lonza Group AG | 7.09B |
| Alcon | 8.12B |
| Sandoz Group AG | 8.42B |
| Straumann Holding AG | 2.58B |
| Sonova Holding AG | 3.85B |
Addex Therapeutics News
- 2 days ago - Earnings Scheduled For December 4, 2025 - Benzinga
- 2 days ago - Addex Therapeutics GAAP EPS of -CHF 0.01, income of CHF 0.05M - Seeking Alpha
- 2 days ago - Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 days ago - Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025 - GlobeNewsWire
- 2 months ago - Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid ... - GuruFocus
- 2 months ago - Q2 2025 Addex Therapeutics Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Earnings Scheduled For September 30, 2025 - Benzinga